Results from New Clinical Trial of Buprenorphine in Young Adults

This clinical trial evaluates the efficacy of continuing Buprenorphine-Naloxone for 12
weeks versus detoxification for opioid-addicted youth. The number of patients younger than 18 years
was too small to analyze separately, but overall, patients in the detox group had higher
proportions of opioid-poisitive urine test results at weeks 4 and 8 but not at week 12.